Drospirenone and estetrol: evaluation of a newly approved novel oral contraceptive-Reference-Cited by-同舟云学术

Drospirenone and estetrol: evaluation of a newly approved novel oral contraceptive

Published:2023-10-16 Issue:16 Volume:24 Page:1757-1764
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Nelson Anita L.¹

Affiliation:

1. Obstetrics and Gynecology, College of Osteopathic Medicine, Western University of Health Sciences, Pomona, CA, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2023.2247979

Reference54 articles.

1. UNFPA State of the World Population 2022 Seeing the unseen: the case for action in the neglected crisis of unintended pregnancy. [cited 2023 May 18]. Available from: https://www.unfpa.org/sites/default/files/pub-pdf/EN_SWP22%20report_0.pdf.

2. Maternal mortality rates in the United States, 2021

3. Use of contraception among reproductive-aged women in the United States, 2014 and 2016

4. A systematic review and meta‐analysis of venous thrombosis risk among users of combined oral contraception

5. Predictors of contraceptive switching and discontinuation within the first 6 months of use among Highly Effective Reversible Contraceptive Initiative Salt Lake study participants

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perimenopause;Advances in Medical Technologies and Clinical Practice;2024-05-31

2. The impact of 17β-estradiol on the estrogen-deficient female brain: from mechanisms to therapy with hot flushes as target symptoms;Frontiers in Endocrinology;2024-01-08

3. Brazilian Guideline on Menopausal Cardiovascular Health – 2024;Arquivos Brasileiros de Cardiologia;2024

4. Diretriz Brasileira sobre a Saúde Cardiovascular no Climatério e na Menopausa – 2024;Arquivos Brasileiros de Cardiologia;2024